...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Late graft dysfunction after prolonged cold ischemia of the donor kidney: inhibition by cyclosporine (see comments)
【24h】

Late graft dysfunction after prolonged cold ischemia of the donor kidney: inhibition by cyclosporine (see comments)

机译:供体肾脏长时间冷缺血后的晚期移植物功能障碍:环孢霉素的抑制作用(见评论)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The present study was devised to elucidate the influence of prolonged cold ischemia on the development of chronic transplant dysfunction (CTD) in kidney isografts (Brown Norway-->Brown Norway; BN-->BN) and in kidney allografts (BN-->Wistar Agouti/ Rij [WAG]) under temporary cyclosporine (CsA) therapy. METHODS: To induce ischemic injury, BN donor kidneys were preserved for 24 hr in 4 degrees C University of Wisconsin solution before transplantation. Renal function (proteinuria), histomorphology according to the BANFF criteria for CTD, and infiltrating cells were assessed. Grafts were examined both early at days 2, 3, 6, and 10, and late at week 26 (allografts) or at week 52 (isografts). RESULTS: Nonischemic isografts preserved a normal function and morphology. Ischemic isografts developed a progressive proteinuria over time and demonstrated significantly more glomerulopathy with macrophage (Me) infiltration and intimal hyperplasia than nonischemic controls at week 52. During the initial 10 days, there was an increased infiltration of MHC class II+ cells, predominantly CD4+ cells and Mphi, coinciding with up-regulated intercellular adhesion molecule-1 expression. CsA treatment in ischemic isografts inhibited infiltration of MHC II+ cells in the early stage, which was accompanied by significantly less renal damage at week 52 compared with untreated controls (proteinuria: 59+/-8 vs. 134+/-19 mg/24 hr; BANFF score: 2.8+/-0.4 vs. 4.3+/-1.0). Under CsA therapy, 24-hr cold ischemia of the allograft affected neither the onset or progress of proteinuria, nor the histomorphology (BANFF score: 7.8+/-2.4 vs. 7.3+/-1.9). In both ischemic and nonischemic allografts, intercellular adhesion molecule-1 expression and mononuclear cell infiltration (CD4, CD8, Mphi was abundantly present during the first 10 days and function deteriorated rapidly. CONCLUSIONS: Prolonged cold ischemia plays a role in the induction of CTD, but its deleterious effect can be successfully inhibited by CsA. Therefore, the alloantigeneic stimulus is the overriding component in the multifactorial pathogenesis of CTD.
机译:背景:本研究旨在阐明长期冷缺血对肾脏同种异体移植物(布朗挪威->布朗挪威; BN-> BN)和同种异体肾移植(BN- -> Wistar Agouti / Rij [WAG])接受临时环孢霉素(CsA)治疗。方法:为诱发缺血性损伤,将BN供体肾脏在4摄氏度的威斯康星大学大学溶液中保存24小时,然后再进行移植。评估肾功能(蛋白尿),根据BANFF CTD标准的组织形态学和浸润细胞。在第2、3、6和10天早期检查移植物,在第26周(同种异体移植物)或第52周(同种异体移植物)时检查移植物。结果:非缺血性同种异体移植物保持正常功能和形态。缺血性同种异体移植物随时间发展为进行性蛋白尿,并在第52周时表现出比非缺血性对照更大的肾小球病变,并伴有巨噬细胞(Me)浸润和内膜增生。在最初的10天中,MHC II +类细胞(主要是CD4 +细胞和Mphi,与细胞间粘附分子-1表达上调相吻合。缺血性同种异体移植物中的CsA治疗在早期抑制了MHC II +细胞的浸润,与未治疗的对照相比,在52周时肾脏损害明显更少(蛋白尿:59 +/- 8 vs. 134 +/- 19 mg / 24 hr ; BANFF得分:2.8 +/- 0.4与4.3 +/- 1.0)。在CsA治疗下,同种异体移植物的24小时冷缺血既不影响蛋白尿的发作或进展,也不影响组织形态学(BANFF评分:7.8 +/- 2.4与7.3 +/- 1.9)。在缺血和非缺血同种异体移植物中,细胞间粘附分子1的表达和单核细胞浸润(CD4,CD8,Mphi在最初的10天中大量存在,并且功能迅速恶化)。结论:长时间的冷缺血在诱导CTD, CsA可成功抑制其有害作用,因此同种抗原刺激是CTD多因素发病机制中最重要的组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号